Physician

Daniel Hexter, M.D.

According to 2025 Medicare claims, Daniel Hexter, M.D. (NPI: 1942224753) practices neurology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Anne Arundel, MD. This provider's primary affiliated billing organization is DANIEL HEXTER MD PA (NPI: 1861686420; TIN: 260760317) and primary practice location at 21401-7071.

Hexter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 546 traditional Medicare patients, billed 82,963 HCPCS/CPT codes, and received $2,344,905 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 1,529 prescription claims across 236 beneficiaries totaling $2,092,198 in drug costs, led by Gammaked (Immune Globul G/Gly/Iga Avg 46). DME data shows 40 claims. Open Payments data shows 283 records totaling $5,315. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $618,008 to $2,344,905. Similarly, Part D prescription costs have risen steadily, from $771,736 to $2,092,198. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,356 and ending at $26,415.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	637	32,261	$618,008
2016	695	51,063	$870,807
2017	535	75,469	$1,404,591
2018	512	82,302	$2,078,129
2019	530	80,282	$2,166,424
2020	518	69,853	$1,701,089
2021	522	84,391	$2,095,089
2022	549	63,187	$1,425,515
2023	554	48,834	$1,748,372
2024	546	82,963	$2,344,905

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	194	1,142	$771,736
2016	208	1,065	$629,171
2017	220	1,150	$777,044
2018	191	1,124	$825,876
2019	191	1,147	$822,096
2020	327	1,440	$989,162
2021	357	1,906	$1,336,967
2022	213	1,285	$1,200,200
2023	200	1,139	$991,195
2024	236	1,529	$2,092,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$420
2016	N/R	N/R	N/R
2017	N/R	45	$775
2018	N/R	24	$514
2019	N/R	13	$123
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	59	$160,335
2023	N/R	88	$195,208
2024	N/R	40	$204,656

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	125	125	$167
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	181	264	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	165	$97
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	163	290	$79
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	308	421	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammaked	Immune Globul G/Gly/Iga Avg 46	29	812	$415,855
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	29	714	$296,389
Ingrezza	Valbenazine Tosylate	22	660	$172,054
Fingolimod	Fingolimod Hcl	11	330	$79,396
Aptiom	Eslicarbazepine Acetate	19	1,530	$64,053

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	15	$203,504
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	14	$1,038
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	11	$113

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	283	$5,315	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Hexter, M.D.?

Tedicare shows public-source Medicare data for Daniel Hexter, M.D. (NPI 1942224753), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Hexter, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Hexter, M.D.?

Daniel Hexter, M.D. is linked to DANIEL HEXTER MD PA (billing NPI 1861686420) in the available physician profile data.

Does Daniel Hexter, M.D. have Open Payments data?

Daniel Hexter, M.D. has 283 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.